phase readout
saveNCT07593040: Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma
NOT_YET_RECRUITINGupdated 2m ago
community read0 votes
Sponsor: Vall d'Hebron Institute of Oncology. Phase: PHASE2. Conditions: Renal Cell Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that